Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Depixus logo — See biology as it happens

Depixus

See biology as it happens

Founded 2012 France France 47 employees Series A Total: $33.59M Biotechnology

General Information

Company Name Depixus
Founded Year 2012
Location France France
Employees 47
Industries Biotechnology
Funding Stage Series A
Business Model B2B, D2C
Revenue Model Product Sales, Service Fee, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Depixus. To contact Depixus, visit depixus.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Depixus compare?

A PDF of Depixus and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Depixus soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Depixus

Depixus, a Paris-based life science technology company, is redefining the biotechnology landscape with its pioneering technology in magnetic force spectroscopy. This cutting-edge solution enables real-time analysis of individual biomolecular interactions on a vast scale, offering new avenues for researchers to decode disease mechanisms and accelerate the development of effective therapies. Founded in 2012, Depixus aims to revolutionize how biology is studied by allowing scientists to "See biology as it happens."

As of December 2021, Depixus secured a €30.60M Series A investment, highlighting investor confidence in its innovative approach. The round attracted notable investors including Bpifrance, Casdin Capital, Arix Bioscience, and Lansdowne Partners. With its headquarters in France, Depixus is well-positioned in the thriving European biotechnology industry and poised to capitalize on future growth opportunities.

Business keywords: Life Science Technology, Magnetic Force Spectroscopy, Biomolecular Interactions, Real-Time Analysis, Genome Analysis, DNA Analysis, RNA Analysis, Single Molecule Precision, RNA Drug Discovery, Protein-Protein Interaction, Biophysics, Drug Discovery, Compound Screening, Interactomics

Services & Products

MAGNA One equipment
Real-time biomolecular interaction analysis
Parallel interaction analysis
Scientific publications and application notes

Target Customers

Research institutions Biochemists Molecular biologists Life science researchers Academic labs Biotechnology companies

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €30.60M 4
Bpifrance Casdin Capital Arix Bioscience
Bpifrance, Casdin Capital +2
15 Dec 2021
Grant €2.92M 1
EASME - EU Executive Agency for SMEs
01 Nov 2018
Grant €71.43K 1
EASME - EU Executive Agency for SMEs
01 Jul 2016
Venture Round Undisclosed 1
AGORANOV
AGORANOV
01 Mar 2012

Depixus Alternatives & Competitors

View All Alternatives
Depixus vs
Bruker Dynamic Biosensors
Bruker Dynamic Biosensors Germany

Bruker Dynamic Biosensors provides analytical systems for the characterization of biomolecules & mol...

Series A
54 employees
Biopharma, Biotechnology
Compare Depixus vs Bruker Dynamic Biosensors
Depixus vs
LUMICKS
LUMICKS The Netherlands

See more. Know more.

Debt Financing
123 employees
Biotechnology, Life Sciences
Compare Depixus vs LUMICKS
Depixus vs
Synthego
Synthego United States

Your Partner in CRISPR & Molecular Diagnostics

172 employees
AI, Automation
Also compare with: Depixus vs PROTEINA PROTEINA View all alternatives

FAQ About Depixus

See biology as it happens
Depixus was founded in 2012.
Depixus is headquartered in France.
Depixus operates in Biotechnology. Its work centres on Life Science Technology, Magnetic Force Spectroscopy, Biomolecular Interactions and Real-Time Analysis. Its customers include Research institutions, Biochemists and Molecular biologists.
Depixus has a B2B and D2C business model. Its revenue comes from Product Sales, Service Fee and Usage Based.
Depixus has approximately 47 employees.
Depixus has completed 4 funding rounds, raising a total of $33.59M. The latest funding stage is Series A.
Depixus offers: MAGNA One equipment, Real-time biomolecular interaction analysis, Parallel interaction analysis, Scientific publications and application notes.
Top alternatives and competitors to Depixus include Bruker Dynamic Biosensors, LUMICKS, Synthego, Illumina, TippingPoint Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Depixus and Bruker Dynamic Biosensors are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Depixus, https://bouncewatch.com/company/depixus, updated 24 January 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes